High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System
CompletedPhase 4NCT02265848
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Study designed to compare the conventional stimulation programming versus the high frequency stimulation programming of the spinal cord stimulator for subjects who already have a spinal cord stimulator.
Study details
- Official title
- Single Blinded, Randomized Control Trial of High Frequency Stimulation in Subjects With Precision® Spinal Cord Stimulator System to Assess Efficacy and Preferability in Back and Extremity Pain Relief
- Conditions
- Chronic Pain
- Low Back Pain
- Radiculopathy
- Complex Regional Pain Syndrome (CRPS)
- Interventions
- Other: High frequency stimulation
- Other: Low frequency stimulation
- Sponsor
- The Center for Clinical Research, Winston-Salem, NC
- Start date
- 2014-10
- Primary completion
- 2015-01
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Healthy volunteers
- true
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Subject must be 18 years and older, and younger than 70 years of age. 2. Subject has had a Precision® spinal cord stimulator system implanted for chronic painful condition. 3. Subject pain scores \>5 on NPRS Exclusion Criteria: 1. Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain 2. Unstable medical or psychiatric illness 3. Lifetime history of psychosis, hypomania, or mania. 4. Epilepsy, or dementia 5. Substance abuse in the last 6 months 6. Pregnant or breastfeeding 7. Not on contraception for those of childbearing age. (Barrier methods, oral contraception, hormone injections, or surgical sterilization) 8. Treatment with investigational drug within 30 days of screening. 9. Concomitant medication exclusions consisting of medications or herbal agents with central nervous system (CNS) effects with exception of episodic use of sedating antihistamines
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02265848